Yes but I won't put in much as I am expecting scaling so I will invest what I think I am likely to get.
Printable View
Yes but I won't put in much as I am expecting scaling so I will invest what I think I am likely to get.
How much do you think it will get scaled?
Who knows? The company's founders still dominate the register despite the recent sell-down. Whether or not there are sufficient other shareholders, sufficiently enthusiastic about the issue, is the question. On the other hand, it's not a very big issue and there is still a healthy discount from the market price.
It's a healthy discount from the market price but a lot more than I paid for my original shares so I won't be going overboard with my bid!
I think a lot of people are running out of money with all the SPP around so it probably may not be hugely oversubscribed???
Really interested to see what the level of scaling is... still a week to wait I guess
Anyone else jumping in? The share price is dropping and I am beginning to wonder if it will dip below the offer price!
Anyone else jumping in? The share price is dropping and I am beginning to wonder if it will dip below the offer price!
Directors are jumping in (buying on market)...
David Flacks - Chairman - spent $77k at $3.87 to increased the number of AFT shares he holds by 14% to 165,431
Jon Lamb - spent $47k at $3.85 to increase the number of AFT shares he holds by 6% to 220,077
Not sure if they'll also be participating in SPP or not... but regardless, clearly keen to hoover up shares at sub $4.
AFT didn't even put out an NZX announcement late last week to kindly remind everyone that the SPP was closing on Friday 26th June...
Hard not to have confidence in AFT really!
SPP allocations should be known Wednesday next week.
[QUOTE=trader_jackson;825352
AFT didn't even put out an NZX announcement late last week to kindly remind everyone that the SPP was closing on Friday 26th June...[/QUOTE]
Do not think they really needed to.
A tad over 530000 shares being offered to just over 900 share holders.
I trust my ask doesnt get scaled back too much... have high hopes for AFT
I think my application was #360 so I don't think many shareholders applied. I applied at 5:30pm NZT
I didn't apply for a high amount as I thought it would be oversubscribed. Maybe not??
I applied on the 22nd, my number was #233.
Maybe retail investors don't have a heap of spare cash in their pockets atm.
I have to admit I am splashing cash around a lot less than I was a couple of weeks ago. Too many opportunities...
I applied for the same number of shares x$3.75 that I already have as I figured I wouldn't be likely to be allocated any more than that. Maybe I undercooked it but the share price isn't a lot more than the offer price right now.
Same here Tango, If I get my full allocation I've double my holding. I think its the wrong time ( COVID-19 ) for owners to be selling down, disagree with it completely. It shows they see the company as overvalued. Don't want to put too much skin into this one.
Cant really begrudge a small sell down, also given the need to cash out one of the early investment funds. Personally I'm pretty happy that there will be a little bit more liquidity and will be interesting to see how the COVID phase coupled with winter flu season helps sales...
The owners are selling less than 1 million shares... out of 73 million shares they own... aka virtually nothing... maybe want to go and build a deck perhaps... the large majority of the selldown is done by a specialist US fund (CRG) who invested in AFT in 2014, have made a decent chunk of coin, and now wishing to exist - fair enough... but it really isn't the 'owners' selling down (much)... they still own a near ridiculous percentage of the company and I'm sure they'll happily sell down a few million more (via placement) when the share price is $7 or $10 in a few years time ;)
The liquidity increase should mean AFT is more attractive to many.
“ AFT Pharmaceuticals Share Purchase Plan Oversubscribed
AFT Pharmaceuticals Limited (NZX:AFT/ASX:AFP) (AFT) is pleased to announce
that its NZ$2 million share purchase plan (SPP) has closed oversubscribed.
The SPP received strong shareholder support with AFT receiving applications
totalling approximately NZ$9.8 million. Applications will be scaled on a
proportionate basis in accordance with the number of AFT shares held by
applicants on the SPP record date (9 June 2020). Refunds of surplus
application amounts paid will be made to applicants in accordance with the
terms of the SPP offer document. “
wow this is far stronger than what I was expecting! I only applied for about a third more of my total holding... and maybe I won't even get all of mine...
Not sure of how many other SPP's have been 5x oversubscribed (particularly with such a small shareholder base).
ll be intriguing to see if directors were buying into the SPP.
My cost price for my shareholding was only $2 so I am not worried if I don’t get all that I apply for given it’s almost double my original cost 🙂
The value of SPP is very small so it's easy to be oversubscribed imo.
Darn - I had applied for a largish parcel - but looks like I'll get 1/5 of that at best... sigh
But it is nice to see the demand
I will be interested to see how many people applied. I was New Zealand #360 at 5:30pm on closing day but maybe 1000 Aussies applied.
Having said that if the average application was $30k then $9.8m is only 326 applications.
If the average application was $20k then $9.8m is only 490 applications.
I will be interested to know the average application amount. I only applied for enough to match my existing shareholding. After AIA I learned to put in a modest bid and not tie $$$ up for 2 weeks while they muck around.
'
https://investors.aftpharm.com/Downl...701/325591.pdf
1,554 AFT shareholders applied under the SPP with an average application of approximately NZ$6,306.00
According to the annual report, as at 30 April, there were 1337 shareholders... 1554 shareholders have applied, meaning over 200 people have become extra shareholders between 30 April and 9th of June, and it would sound like virtually every single shareholder applied - unprecedented support given the relatively small SPP (not exactly discounted by a huge amount either).
Surprised the share price is under $4 still
That's super interesting. Thanks for digging that out.
If you bought at over $4 it's a bargain. I bought at around $2 so for me it's just a top up of a value share. Not much of a moat as the products are generic but a well run company that understand the business.
Has anyone checked their account yet to see if allocations have been made? I can’t access mine right now but I plan to check in an hour
nothing yet...
Noticed mine came through a short time ago… I only applied for about a third of my holding, and only got given just over a third of that… hard to get in on quality companies!
Yeah, 14.5% is my allocation rate too.
... Mainly because they really didn't need to take any money, to me the SPP was actually a surprise (the sell down wasn't)... this was not an emergency capitalize on a high share price capital raise "like most capital raises" of late... no need to dilute shareholders further
The issue has done a good job in raising awareness of AFT - and its shareprice. Well done the company and its advisers!
TJ, all selling and spp done....SP will be upward from now???
What is the target?
Have you had your $$$ refunded yet? It’s not in my bank account yet :(
No repayment deposited yet.... and they said it was getting paid tomorrow! lol. Be glad when if does finally arrive.
Worst time to have money tied up :(
https://www.directbroking.co.nz/Dire...spx?id=5406372
Wow TJ..this is big!!!
The attached ASX release by RooLife (ASX:RLG) is related to AFT and has therefore been attached to our ASX ticker AFP.
Accordingly we now make the RooLife release available on our NZX ticker.
Issued for and on behalf of AFT Pharmaceuticals Limited by Malcolm Tubby, Chief Financial Officer.
10 July 2020
RooLife & AFT launch Online New Zealand Health Store in China
• RooLife partners with ASX & NZX-listed AFT Pharmaceuticals (ASX:AFP, NZX:AFT) to deliver New Zealand branded online health & pharmacy store in China
• “Kiwi Health” will be the online marketplace in China for AFT Pharmaceuticals’ high-profile, well-known and trusted portfolio of health and wellbeing products
• RooLife to provide digital marketing, e-Commerce operation and sales in China
• “Kiwi Health” will expand RooLife’s and AFT’s revenue streams on Alibaba’s Tmall and Alipay’s platform with health products expected to be in strong demand
• Three-year contract expected to deliver revenue of $2.2 million to RooLife based on services fees and annual sales targets being met
• Latest agreement takes the value of RooLife’s announced contract wins since March 2020 to $6 million in value, subject to minimum annual sales targets being met for each respective contract .
• RooLife Q4 FY2020 unaudited Revenue of $1m+ (up +25% over prior Quarter) during challenging market conditions
• RooLife is now marketing and selling products in China from Australia, New Zealand, U.S.A. and United Kingdom
• Third RooLife Tmall store appointment and launch secured in the last 4 months
e-Commerce marketing and Artificial Intelligence (AI) company RooLife Group Ltd (ASX:RLG) (“RooLife”) is delighted to be appointed by ASX and NZX listed AFT Pharmaceuticals (“AFT”) to launch and operate a New Zealand branded health & pharmacy store selling key AFT products on Alibaba’s Tmall platform.
The three-year contract expands RooLife’s Alibaba Tmall revenues and provides RooLife a mixture of monthly service fees and product sales revenue from marketing and selling products within the AFT range.
The contract, which is subject to ongoing sales performance milestones, is expected to deliver total revenue for the RooLife Group of approximately $2.2m over a three year period if minimum sales targets, which are scaled up each year, are met.
The new Kiwi Health store will market and sell a range of health and well-being products online in China leveraging the strong brand awareness of AFT’s product range using the “Kiwi’s thinking about health” branding.
Kiwi Health Tmall Store Launching on Alibaba – “Kiwi’s thinking about health”
AFT Founder and CEO, Dr Hartley Atkinson says that he is very pleased to further extend the company’s offering to consumers via Online China, “With a population of over 1.4 billion1 (2020), and with our products already having a strong following by the local Chinese consumer living in New Zealand, we believe that a Tmall flagship store along with amplifying our online presence in China, represents great potential for our health and well-being portfolio’s future growth,” said Dr Atkinson.
RooLife Managing Director, Bryan Carr commented, “Working with AFT Pharmaceuticals to market and sell their well-known, trusted portfolio of health and wellbeing products in the Chinese market under the Kiwi Health banner is an attractive growth opportunity for RooLife.
We have seen the successes achieved by large Australian and NZ based pharmacy chains online in China and we are excited by the opportunity available with AFT Pharmaceuticals’ range of products, leveraging the high regard for New Zealand and its products with Chinese shoppers.”
The latest contract is expected to contribute to the continued revenue growth RooLife has achieved in the last 18 months with growth of 490% achieved in FY19 and 380% achieved in FY20.
Continuing to build on the strong revenue base achieved in Financial Year 2020, RooLife has announced three new contract wins totalling $6 million in revenue expected this year and over the next two years, subject to the respective minimum sales performance milestones being met.
RooLife Strong Year-on-Year Revenue Growth (*Based on minimum sales performance milestones)
RooLife has achieved strong revenue growth this year with unaudited revenue of over $1 million for the Quarter ended 30 June 2020 and we are seeing solid demand for health and well-being products such as those provided by AFT and we expect this new agreement to contribute to further sales growth this financial year.
The RooLife platform provides an international gateway for products and services for companies wishing to enter the China market. RooLife is now representing and driving sales for a growing number of quality products and brand names into China for companies from Australia, New Zealand, U.S.A and the United Kingdom.”
ENDS
1. Source: http://www.worldometers.info/world-p...ina-population
Issued by: RooLife Group Ltd
Authorised by: The Board of RooLife Group Ltd
For further information, please visit the RooLife website at www.roolifegroup.com.au and www.aftpharm.co.nz or contact:
Bryan Carr
Managing Director
Ph: +61 8 6444 1702
Email: ir@roolifegroup.com.au
Peter Nesveda
Corporate Affairs & International Investor Relations
Ph: +61 412 357 375
peter@intuitiveaustralia.com.au
Sarah Lenard – Advisir
Investor Relations/Media Contact
Telephone: +61 432 332 905
Email: sarah.lenard@advisir.com.au
About RooLife Group Ltd (ASX:RLG)
www.roolifegroup.com.au
The RooLife Group of companies provides fully integrated digital marketing and customer acquisition services focusing on driving online sales of products and services for its clients. Powered by the Group’s hyper personalisation and profiling Artificial Intelligence System, RooLife provides personalised real-time, targeted marketing. With a key focus on driving sales in Australia and China the company’s online e-Commerce marketplace assists businesses to sell directly to Chinese consumers and accept payment via the WeChat and Alipay mobile payments platforms. RooLife’s key positioning is about knowing and remaining connected with Chinese consumers, allowing brands to continually sell products to Chinese consumers based on their profiles and purchasing behaviours.
New Contract Revenue FY21+*
Nurea Beauty $1.3m
Colab $2.5m
Kiwi Health $2.2m
TOTAL $6.0m
About AFT Pharmaceuticals (ASX:AFP, NZX:AFT)
www.aftpharm.com
AFT Pharmaceuticals are a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital. AFT's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.
You may as well just pm that to each other and hold hands:D.
Heres one from the source that everyone can read.looks good
RooLife ASX announcement
would love to hold hands together and go to have ice cream later??
Too late the ASX and NZX announcements come out 20 mins earlier, me and everyone else long gone.
honestly this companies forecast and potential is okay, but what is it with the liquidity, the capital raising hardly helped
70persen owned by the owner.....pretty safe!!
With rooflife announcement.....AFT will be able to sell thier products to china..
With pandemic still on...the demand of AFT products will be massive!
TJ is this you selling after ramping it up?
I'm a buyer anywhere under $4
I grabbed $10K at $4.01. Not sure why anyone was selling at that price, but good for me :t_up:
It has been aired for along time....time to get off pornhub n watch more NZ tv....lol
Nah mate.....that is cost savings.....why would u hire anyone if the owner himself can do the ad?...it saves money...no?
Exactly... I personally think it is great, whack an ad together that gets straight to the hard hitting points... with a free (and only) actor... no fancy CGI or expensive sets.
Where AFT spend most of their money is Australia... I believe they have a very similar ad airing in Aussie... In fact I am pretty sure it is a couple years old! (not making a new one every 5 minutes... that is expensive stuff!)
It worked for Alan Martin, many years ago.
It's OK folks..... each to their own.
My concern is that for an international company to really grow, we need evidence of a strong team.
Reliance on one person (no matter how able or how great or cheap the advertising) is a risk at some stage.
If covid vaccine available in the bear future, will AFT be appointed as the dealer?
They did. They signed MoU cannabis with SETEK last year....so a channel had been established
Huge discrepancy in pricing between asx and nzx right now.
What is the code for the Ozzie market?
Au AFP.
nah...it won't get the Ozzie punters excited about this company...unless a significant deal about cannabis ....then they will love it
Man, had to go all the way to page 4 to find this thread... NZ obviously doesn't care much for arguably one of its greatest growth companies with a great story... anyhow...
https://www.nzx.com/announcements/357014
Good to see this today, could (if not probably will) result in millions of dollars of extra revenue for AFT in this financial year alone... Some might say this should be price sensitive but ah well.
Atkinson talking at a NZSA zoom meeting tonight
You going to tune in tj?
Might seduce a few more new 'investors'
Good hold. Current tailwind. Await AGM and interim if the momentum continues I might actually Agree with TJ about AFT for once
average recent price around 420 ;)
Elon will be buying soon.
Attachment 11817
NZSA Auckland Branch Meeting, Wednesday 29th July
Transmission will commence at 7.30pm and the speakers are:-
7.35pm approx. - Dr Hartley Atkinson, CEO, AFT Pharmaceuticals
8.00pm approx. - Felix Fok, Portfolio Manager, MAM Global Equity Fund
The meeting will be held at the Ellerslie Event Centre in the Great Northern Room on level 1 (second floor) of the Ellerslie Stand.
Non-members welcome: $5 entry
Happy to see the tailwind I’m happy to be a long term holder and always buying on any weakness